Gene · 1240
Papers1,391
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,391
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chemerin - CMKLR1 signaling contributes to immune metabolic dysfunction in salt-sensitive hypertension. | Clin Exp Hypertens | 2026 | 42802577 | PubTator, text mining | PubMed |
| Combining pro-resolving therapy with cyclosporine A restores immune homeostasis and reduces toxicity in autoimmune bone marrow failure. | Cell Rep Med | 2026 | 42785302 | PubTator, text mining | PubMed |
| CXCR4+ circulating tumor cells (CTCs) accumulate in subcutaneous, immune suppressive, CXCL12-loaded-hydrogel. | Mater Today Bio | 2026 | 42733769 | PubTator, text mining | PubMed |
| Characterization of posttranslational modification in metabolic dysfunction-associated steatohepatitis: acetylation, lactylation, and phosphorylation. | J Lipid Res | 2026 | 42537908 | PubTator, text mining | PubMed |
| Protocol for studying Chemerin 15-enhanced microglial phagocytosis in cerebral ischemia-reperfusion injury via the ChemR23/p38 MAPK pathway. | STAR Protoc | 2026 | 42490223 | PubTator, text mining | PubMed |
| Coexpression of GITRL confers resistance to Treg cell-mediated immunosuppression to anti-CD19 CAR-NK cells. | Front Immunol | 2026 | 42488650 | PubTator, text mining | PubMed |
| Chemerin Normal Function and Roles in Metabolic and Nonmetabolic Disorders: An Up-To-Date Comprehensive Review. | Biochem Res Int | 2026 | 42415929 | PubTator, text mining | PubMed |
| Targeted, receptor-mediated delivery of a masked d-amino acid cell-penetrating peptide for cell-specific phototoxicity. | FEBS J | 2026 | 42212778 | PubTator, text mining | PubMed |
| Consistent Metabolomic and Genetic Evidence Supports Acisoga as a Key Contributor to Colorectal Neoplasia Progression. | Cancer Epidemiol Biomarkers Prev | 2026 | 42201318 | PubTator, text mining | PubMed |
| Erratum for the Research Article "The chemerin-CMKLR1 axis limits thermogenesis by controlling a beige adipocyte/IL-33/type 2 innate immunity circuit". | Sci Immunol | 2026 | 42030374 | PubTator, text mining | PubMed |
| Chemerin as a Novel Mediator of Fetal Endothelial Dysfunction in Gestational Diabetes Mellitus: Integration of Bioinformatics, Clinical, and In Vitro Evidence. | J Obstet Gynaecol Res | 2026 | 41947503 | PubTator, text mining | PubMed |
| Decoding chemerin proteolytic processing and isoform signaling across disease contexts. | iScience | 2026 | 41907444 | PubTator, text mining | PubMed |
| Restriction of HSV-1 replication by Pistacia vera L. extracts reveals a promising strategy for regulating virus-mediated chemokine response in monocytic cells. | Sci Rep | 2026 | 41904200 | PubTator, text mining | PubMed |
| Blood and Saliva Composition in Cancer: Similarities or Differences? | Curr Issues Mol Biol | 2026 | 41899459 | PubTator, text mining | PubMed |
| Chemokine-Like Receptor 1 Knockdown Suppresses Oral Squamous Cell Carcinoma Progression by Reducing Oxidative Phosphorylation. | Int Dent J | 2026 | 41850175 | PubTator, text mining | PubMed |
| Evaluation of chemerin levels in the pathogenesis of psoriasis. | Front Med (Lausanne) | 2026 | 41788726 | PubTator, text mining | PubMed |
| Genomic landscape, immune microenvironment and survival in male versus female breast cancer. | ESMO Open | 2026 | 41785670 | PubTator, text mining | PubMed |
| Exploring the role of chemerin in skeletal muscle phenotype in those with kidney disease. | Transl Res | 2026 | 41759781 | PubTator, text mining | PubMed |
| Locating the epileptogenic zone for drug-resistant epilepsy through neuroelectrophysiological brain network topology. | Front Neurosci | 2026 | 41756002 | PubTator, text mining | PubMed |
| Cutaneous Dendritic Cells: Structure, Function and Immune Role. | Biomedicines | 2026 | 41751359 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1240/papers